SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-11-001268
Filing Date
2011-08-15
Accepted
2011-08-15 07:23:23
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 biostarpharma10q063011.htm 10-Q 1244889
2 ex31-1.htm EX-31.1 17065
3 ex31-2.htm EX-31.2 17332
4 ex32-1.htm EX-32.1 6321
5 ex32-2.htm EX-32.2 6225
  Complete submission text file 0001185185-11-001268.txt   3682116

Data Files

Seq Description Document Type Size
6 bspm-20110630.xml EX-101.INS 544491
7 bspm-20110630.xsd EX-101.SCH 18122
8 bspm-20110630_cal.xml EX-101.CAL 26298
9 bspm-20110630_def.xml EX-101.DEF 79993
10 bspm-20110630_lab.xml EX-101.LAB 107526
11 bspm-20110630_pre.xml EX-101.PRE 91987
Mailing Address 11 EAST 86TH STREET, SUITE 19 B NEW YORK NY 10028
Business Address 11 EAST 86TH STREET, SUITE 19 B NEW YORK NY 10028 1-646-623-6999
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 111033157
SIC: 2834 Pharmaceutical Preparations